Dr Daniel Landau Presents CALQUENCE Long-Term and Pooled Cardiovascular Safety Data for CLL/SLL Published 2022-01-06 Download video MP4 360p Download video MP4 720p Recommendations 2:04:16 Living with Chronic Lymphocytic Leukemia (CLL): A CALQUENCE™ Connections Virtual Event 10:46 CALQUENCE® (acalabrutinib) Patient Testimonials: Doreen’s Story 08:28 Sharon's Treatment Story 11:41 CALQUENCE® (acalabrutinib) Safety Data – Dr Levy, MD 03:48 Cliff’s Story: Living with CLL 02:10 How CALQUENCE® (acalabrutinib) Works 16:53 CALQUENCE® (acalabrutinib) Pooled CV Safety Analysis – Dr Pinilla-Ibarz, MD 01:01 Focus on the Things You're Loving 02:32 Jane’s Story: Caring for Someone Living with CLL 11:56 CALQUENCE® (acalabrutinib) Mechanism of Action (MOA) – Dr Pearson, MD 14:51 CALQUENCE® (acalabrutinib) ELEVATE-TN, incl. High-Risk Subgroups – Dr Abutalib, MD Similar videos 58:26 Treating Chronic Lymphocytic Leukemia (CLL): A CALQUENCE™ Connections Event 1:09:24 Chronic Lymphocytic Leukemia During COVID: A Patient Story 31:15 CALQUENCE® (acalabrutinib) Clinical Insights from a Real-World Patient with Treatment Naive CLL 52:19 A Chronic Lymphocytic Leukemia (CLL) Treatment Overview: A CALQUENCE™ Connections Virtual Event 04:33 CALQUENCE® (acalabrutinib) Patient Testimonials: Marialice’s Story 04:06 CALQUENCE® (acalabrutinib) Patient Testimonials: Jim’s Story 18:37 AstraZeneca's Dr. Niko Andre Discusses Leukemia & Lymphoma Drug CALQUENCE | Interview 08:58 AstraZeneca's New CALQUENCE® Data in Mantle Cell Lymphoma (MCL) 02:43 What Are Common CLL Treatment Side Effects? 01:24 5-year update of ELEVATE CLL TN 57:33 2022 IWMF Ed Forum-Everything You Want to Know About BTK Inhibitors, Do's and Don'ts 00:57 Acalabrutinib Appears Tolerable in Chronic Lymphocytic Leukemia 10:07 Calquence Medication: Understanding its Benefits and Side Effects 07:48 ACALABRUTINIB, What is acalabrutinib used for, Acalabrutinib CALQUENCE review 07:27 Acalabrutinib Vs Ibrutinib For Previously Treated CLL 03:16 Ida McCain - Dr. Barnes More results